Cangrelor cuts complications at PCI vs clopidogrel in CHAMPION-PHOENIX; bleeding a caution

PCI indication didn't matter: the risk of periprocedural complications like MI or stent thrombosis fell with the newer ADP-receptor blocker, given intravenously, compared with oral clopidogrel. Whether bleeding risks were similar depended on how bleeding is defined.
Source: theHeart.org - Category: Cardiology Source Type: news